[HTML][HTML] Repurposing drugs to treat neurological diseases
TH Massey, NP Robertson - Journal of neurology, 2018 - Springer
The development of new drugs can be expensive: on average, it costs over $2 billion to take
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
[PDF][PDF] Repurposing drugs to treat neurological diseases
T Massey, N Robertson - Journal of Neurology, 2018 - orca.cardiff.ac.uk
The development of new drugs can be expensive: on average, it costs over $2 billion to take
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
Repurposing drugs to treat neurological diseases.
TH Massey, NP Robertson - Journal of Neurology, 2018 - search.ebscohost.com
The article highlights various papers about drug repurposing for the treatment of
neurological diseases. Topics mentioned include the risk ofß2-adrenoreceptor to regulate …
neurological diseases. Topics mentioned include the risk ofß2-adrenoreceptor to regulate …
[HTML][HTML] Repurposing drugs to treat neurological diseases
TH Massey, NP Robertson - Journal of Neurology, 2018 - ncbi.nlm.nih.gov
The development of new drugs can be expensive: on average, it costs over $2 billion to take
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
Repurposing drugs to treat neurological diseases.
TH Massey, NP Robertson - Journal of Neurology, 2018 - europepmc.org
The development of new drugs can be expensive: on average, it costs over $2 billion to take
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
[PDF][PDF] Repurposing drugs to treat neurological diseases
TH Massey, NP Robertson - Journal of Neurology, 2018 - scienceopen.com
The development of new drugs can be expensive: on average, it costs over $2 billion to take
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
[引用][C] Repurposing drugs to treat neurological diseases
TH Massey, NP Robertson - Journal of neurology, 2018 - pubmed.ncbi.nlm.nih.gov
Repurposing drugs to treat neurological diseases Repurposing drugs to treat neurological
diseases J Neurol. 2018 Feb;265(2):446-448. doi: 10.1007/s00415-018-8732-z. Authors TH …
diseases J Neurol. 2018 Feb;265(2):446-448. doi: 10.1007/s00415-018-8732-z. Authors TH …
[引用][C] Repurposing drugs to treat neurological diseases
TH Massey, NP Robertson - Journal of Neurology, 2018 - search.proquest.com
The development of new drugs can be expensive: on average, it costs over $2 billion to take
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
a medication from inception to clinical practice. Drug discovery is particularly difficult in …
Repurposing drugs to treat neurological diseases.
TH Massey, NP Robertson - Journal of Neurology, 2018 - europepmc.org
This is a comment on" Clemastine fumarate as a remyelinating therapy for multiple sclerosis
(ReBUILD): a randomised, controlled, double-blind, crossover trial." Lancet. 2017 Dec 2; …
(ReBUILD): a randomised, controlled, double-blind, crossover trial." Lancet. 2017 Dec 2; …